The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Condon, Richard Michael
    Director born in August 1976
    Individual (9 offsprings)
    Officer
    2023-04-28 ~ now
    OF - director → CIF 0
  • 2
    May, Jonathan Charles
    Director born in April 1970
    Individual (11 offsprings)
    Officer
    2020-06-15 ~ now
    OF - director → CIF 0
  • 3
    Buckley, Gary David
    Director born in February 1986
    Individual (11 offsprings)
    Officer
    2020-06-15 ~ now
    OF - director → CIF 0
    Buckley, Gary David
    Individual (11 offsprings)
    Officer
    2020-06-15 ~ now
    OF - secretary → CIF 0
  • 4
    102, High Street, Godalming, England
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    4,689,997 GBP2023-12-31
    Person with significant control
    2019-09-19 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 13
  • 1
    Podolsky, Craig
    Investment Professional born in February 1981
    Individual (10 offsprings)
    Officer
    2020-06-15 ~ 2021-09-03
    OF - director → CIF 0
  • 2
    Jacobson, Ian
    Chief Executive born in March 1960
    Individual (12 offsprings)
    Officer
    2014-12-09 ~ 2021-09-03
    OF - director → CIF 0
  • 3
    Kahan, Barbara
    Director born in June 1931
    Individual (456 offsprings)
    Officer
    2009-02-24 ~ 2009-02-24
    OF - director → CIF 0
  • 4
    Roberts, Mark Derek
    Company Director born in August 1967
    Individual (12 offsprings)
    Officer
    2014-12-09 ~ 2021-09-03
    OF - director → CIF 0
  • 5
    Fraser-pye, Graham Julian
    Pharmaceuticals born in March 1968
    Individual (17 offsprings)
    Officer
    2009-06-22 ~ 2021-09-03
    OF - director → CIF 0
  • 6
    Green, Julie Anne
    Pharmaceutical Operations born in May 1957
    Individual (1 offspring)
    Officer
    2009-06-22 ~ 2013-11-21
    OF - director → CIF 0
  • 7
    Douglas, James
    Director born in July 1971
    Individual
    Officer
    2009-02-24 ~ 2009-05-14
    OF - director → CIF 0
  • 8
    Kadis, Dimitris
    Born in May 1976
    Individual (1 offspring)
    Officer
    2010-01-11 ~ 2010-10-11
    OF - director → CIF 0
  • 9
    Hill, Jane
    Sales Director born in February 1976
    Individual (2 offsprings)
    Officer
    2009-05-14 ~ 2011-02-28
    OF - director → CIF 0
  • 10
    Damanakis, Emmanouil
    Attorney At Law born in April 1955
    Individual
    Officer
    2010-11-15 ~ 2014-12-09
    OF - director → CIF 0
  • 11
    Roberts, Debra Joy
    Financial Director born in January 1962
    Individual (1 offspring)
    Officer
    2013-11-12 ~ 2020-05-31
    OF - director → CIF 0
    Roberts, Debra Joy
    Individual (1 offspring)
    Officer
    2013-11-12 ~ 2020-05-31
    OF - secretary → CIF 0
  • 12
    102, High Street, Godalming, England
    Corporate (7 parents, 1 offspring)
    Equity (Company account)
    12,069,492 GBP2020-12-31
    Person with significant control
    2019-09-04 ~ 2019-09-19
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more with control over the trustees of a trust → CIF 0
  • 13
    102, High Street, Godalming, England
    Corporate (8 parents, 1 offspring)
    Equity (Company account)
    2,552,085 GBP2020-12-31
    Person with significant control
    2016-04-06 ~ 2019-09-04
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

ASPIRE PHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Cost of Sales
-63,237,459 GBP2023-01-01 ~ 2023-12-31
-46,140,892 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
-15,655,697 GBP2023-01-01 ~ 2023-12-31
-14,524,852 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
100,320 GBP2023-01-01 ~ 2023-12-31
21,877 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
20,320,873 GBP2023-01-01 ~ 2023-12-31
20,557,617 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
19,533,952 GBP2023-01-01 ~ 2023-12-31
19,837,187 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
19,533,952 GBP2023-01-01 ~ 2023-12-31
19,837,187 GBP2022-01-01 ~ 2022-12-31
Intangible Assets
Goodwill
5,120,668 GBP2023-12-31
6,128,013 GBP2022-12-31
Other
8,764,324 GBP2023-12-31
6,182,292 GBP2022-12-31
Intangible Assets
13,884,992 GBP2023-12-31
12,310,305 GBP2022-12-31
Property, Plant & Equipment
173,441 GBP2023-12-31
139,076 GBP2022-12-31
Fixed Assets
14,058,433 GBP2023-12-31
12,449,381 GBP2022-12-31
Debtors
30,955,575 GBP2023-12-31
27,088,014 GBP2022-12-31
Cash at bank and in hand
9,678,345 GBP2023-12-31
8,838,159 GBP2022-12-31
Current Assets
63,239,714 GBP2023-12-31
52,678,925 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-27,770,453 GBP2023-12-31
-16,911,355 GBP2022-12-31
Net Current Assets/Liabilities
35,469,261 GBP2023-12-31
35,767,570 GBP2022-12-31
Total Assets Less Current Liabilities
49,527,694 GBP2023-12-31
48,216,951 GBP2022-12-31
Net Assets/Liabilities
48,507,716 GBP2023-12-31
48,216,951 GBP2022-12-31
Equity
Called up share capital
2,600,003 GBP2023-12-31
2,600,003 GBP2022-12-31
2,600,003 GBP2021-12-31
Share premium
899,998 GBP2023-12-31
899,998 GBP2022-12-31
899,998 GBP2021-12-31
Retained earnings (accumulated losses)
45,007,715 GBP2023-12-31
44,716,950 GBP2022-12-31
42,729,763 GBP2021-12-31
Equity
48,507,716 GBP2023-12-31
48,216,951 GBP2022-12-31
Profit/Loss
Retained earnings (accumulated losses)
19,533,952 GBP2023-01-01 ~ 2023-12-31
19,837,187 GBP2022-01-01 ~ 2022-12-31
Dividends Paid
Retained earnings (accumulated losses)
-17,850,000 GBP2022-01-01 ~ 2022-12-31
Dividends Paid
-19,243,187 GBP2023-01-01 ~ 2023-12-31
Audit Fees/Expenses
26,000 GBP2023-01-01 ~ 2023-12-31
22,650 GBP2022-01-01 ~ 2022-12-31
Average Number of Employees
792023-01-01 ~ 2023-12-31
712022-01-01 ~ 2022-12-31
Wages/Salaries
4,016,595 GBP2023-01-01 ~ 2023-12-31
3,326,642 GBP2022-01-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
250,198 GBP2023-01-01 ~ 2023-12-31
195,180 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
4,681,337 GBP2023-01-01 ~ 2023-12-31
3,824,818 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-125,451 GBP2023-01-01 ~ 2023-12-31
-242,229 GBP2022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Goodwill
10,466,145 GBP2023-12-31
10,466,145 GBP2022-12-31
Patents/Trademarks/Licences/Concessions
10,568,462 GBP2023-12-31
7,500,019 GBP2022-12-31
Development expenditure
4,308,454 GBP2023-12-31
3,854,038 GBP2022-12-31
Intangible Assets - Gross Cost
27,981,936 GBP2023-12-31
24,173,126 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
5,345,477 GBP2023-12-31
4,338,132 GBP2022-12-31
Patents/Trademarks/Licences/Concessions
5,224,762 GBP2023-12-31
4,547,369 GBP2022-12-31
Development expenditure
1,963,827 GBP2023-12-31
1,690,594 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
14,096,944 GBP2023-12-31
11,862,822 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Goodwill
1,007,345 GBP2023-01-01 ~ 2023-12-31
Patents/Trademarks/Licences/Concessions
592,723 GBP2023-01-01 ~ 2023-12-31
Development expenditure
117,211 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
1,922,237 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
5,343,700 GBP2023-12-31
2,952,651 GBP2022-12-31
Development expenditure
2,344,627 GBP2023-12-31
2,163,444 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
101,880 GBP2023-12-31
29,100 GBP2022-12-31
Furniture and fittings
435,674 GBP2023-12-31
375,200 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
537,554 GBP2023-12-31
404,300 GBP2022-12-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
0 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
-436 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals
-436 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
41,181 GBP2023-12-31
17,156 GBP2022-12-31
Furniture and fittings
322,932 GBP2023-12-31
248,068 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
364,113 GBP2023-12-31
265,224 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
24,025 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
75,293 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
99,318 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
0 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
-429 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-429 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Plant and equipment
60,699 GBP2023-12-31
11,944 GBP2022-12-31
Furniture and fittings
112,742 GBP2023-12-31
127,132 GBP2022-12-31
Finished Goods/Goods for Resale
22,605,794 GBP2023-12-31
16,752,752 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
13,398,320 GBP2023-12-31
13,172,569 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
4,841,864 GBP2023-12-31
1,803,198 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
11,491,079 GBP2023-12-31
11,504,266 GBP2022-12-31
Other Debtors
Current
6,755 GBP2023-12-31
0 GBP2022-12-31
Prepayments/Accrued Income
Current
1,217,557 GBP2023-12-31
579,236 GBP2022-12-31
Debtors - Deferred Tax Asset
Current
0 GBP2023-12-31
28,745 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
30,955,575 GBP2023-12-31
27,088,014 GBP2022-12-31
Trade Creditors/Trade Payables
Current
17,494,467 GBP2023-12-31
8,906,261 GBP2022-12-31
Other Taxation & Social Security Payable
Current
2,820,278 GBP2023-12-31
2,697,442 GBP2022-12-31
Other Creditors
Current
7,455,708 GBP2023-12-31
5,307,652 GBP2022-12-31
Deferred Tax Liabilities
1,019,978 GBP2023-12-31
Equity
Called up share capital
100,002 GBP2023-12-31
100,002 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
237,891 GBP2023-12-31
121,558 GBP2022-12-31
Between two and five year
691,175 GBP2023-12-31
456,008 GBP2022-12-31
More than five year
0 GBP2023-12-31
65,333 GBP2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
929,066 GBP2023-12-31
642,899 GBP2022-12-31
Related profiles found in government register
  • ASPIRE PHARMA LIMITED
    Info
    Registered number 06828501
    102 High Street, Godalming, Surrey GU7 1DS
    Private Limited Company incorporated on 2009-02-24 (16 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-22
    CIF 0
  • ASPIRE PHARMA LIMITED
    S
    Registered number 06828501
    102, High Street, Godalming, England, GU7 1DS
    Private Limited Cpmpany in Companies House, England And Wales
    CIF 1
  • ASPIRE PHARMA LIMITED
    S
    Registered number 06828501
    102, High Street, Godalming, Surrey, England, GU7 1DS
    Private Limited Company in Companies House, England
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    Elizabeth House, 13-19 London Road, Newbury, Berkshire, United Kingdom
    Corporate (4 parents)
    Equity (Company account)
    219,067 GBP2024-03-06
    Person with significant control
    2024-03-07 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE
  • 2
    102 High Street, Godalming, Surrey, England
    Corporate (3 parents)
    Equity (Company account)
    100 GBP2023-12-31
    Person with significant control
    2019-02-08 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.